First-pass extracted concept

CRISPR-Cas arrays

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

These ancient photosynthetic organisms possess a diverse array of restriction-modification (R-M) systems and CRISPR-Cas arrays that present challenges for genetic engineering, but also offer unique opportunities for cancer-targeted biotechnological applications.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1application potentialsupports2026Source 1DOI PubMed

Cyanobacterial defense systems may offer opportunities for cancer-targeted biotechnological applications.

Quoted textsource-backed

but also offer unique opportunities for cancer-targeted biotechnological applications

Claim 2biological prevalencesupports2026Source 1DOI PubMed

Cyanobacteria possess diverse restriction-modification systems and CRISPR-Cas arrays.

Quoted textsource-backed

These ancient photosynthetic organisms possess a diverse array of restriction-modification (R-M) systems and CRISPR-Cas arrays

Claim 3engineering constraintsupports2026Source 1DOI PubMed

Cyanobacterial restriction-modification systems and CRISPR-Cas arrays present challenges for genetic engineering.

Quoted textsource-backed

restriction-modification (R-M) systems and CRISPR-Cas arrays that present challenges for genetic engineering

Claim 4tool usesupports2026Source 1DOI PubMed

Prokaryotic defense systems are currently used in molecular applications as gene editing tools.

Quoted textsource-backed

These systems exist in prokaryotes mainly as defense mechanisms but they are currently used in molecular applications as gene editing tools.